V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014244 | 270009894 | 1.62 | 74.4 | Adjuvant (A) | 2015-11-17 | 2016-02-23 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270017207 | CARBOPLATIN |
| 270014245 | 270009894 | null | 54.6 | Not known (9) | 2015-09-27 | 2016-05-31 | Irinotecan | N | N | 270017207 | IRINOTECAN |
| 270014246 | 270009895 | 1.67 | 70.5 | Curative (C) | 2014-01-22 | 2014-02-25 | Oxaliplatin + Raltitrexed | N | N | 270017209 | BEVACIZUMAB |
| 270014247 | 270009898 | null | 83.9 | Curative (C) | 2017-03-15 | 2018-02-19 | Cyclophosphamide High Dose | N | null | 270017211 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014248 | 270009900 | null | 60.3 | null | 2015-05-24 | 2015-05-31 | Bevacizumab 5mg/kg | N | N | 270017212 | CETUXIMAB + OXALIPLATIN + MDG |
| 270014249 | 270009901 | 1.6 | 71.2 | Palliative (P) | 2015-08-29 | 2016-06-13 | Irinotecan | N | N | 270017213 | IRINOTECAN |
| 270014250 | 270014629 | 1.64 | null | Adjuvant (A) | 2013-06-07 | 2013-06-23 | Panitumumab | N | N | 270017220 | BEVACIZUMAB |
| 270014251 | 270014629 | 1.7 | null | Curative (C) | 2014-12-19 | 2014-12-25 | Vinblastine | N | N | 270017220 | IGEV |
| 270014252 | 270014629 | null | 53.7 | Palliative (P) | 2016-07-19 | 2016-07-22 | R ABVD | N | null | 270017220 | NIVOLUMAB |
| 270014253 | 270009902 | 1.6 | 77 | null | 2014-01-04 | 2014-01-11 | ABVD R | 02 | N | 270017229 | BEVACIZUMAB |
| 270014254 | 270009906 | 1.7 | 98 | Not known (9) | 2014-09-26 | 2014-11-07 | Carboplatin AUC 2 - 5 | N | N | 270017233 | BEVACIZUMAB |
| 270014255 | 270009907 | 1.76 | 56 | Adjuvant (A) | 2016-10-04 | 2017-01-05 | Panitumumab | 02 | N | 270017240 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014256 | 270009907 | 1.8 | 66 | Adjuvant (A) | 2016-08-01 | 2016-08-01 | Panitumumab | 02 | N | 270017240 | BEVACIZUMAB |
| 270014257 | 270009909 | 1.8 | 73.6 | Adjuvant (A) | 2018-02-01 | 2018-02-01 | BENDAMUSTINE | 2 | N | 270017244 | BENDAMUSTINE |
| 270014258 | 270009910 | 1.86 | null | Not known (9) | 2018-02-04 | 2018-02-08 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270017246 | ABVD R |
| 270014259 | 270009913 | 1.76 | 60 | Not known (9) | 2014-06-14 | 2014-06-26 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 270017248 | PANITUMUMAB |
| 270014260 | 270009914 | 1.68 | 78.4 | Not known (9) | 2015-02-20 | 2015-12-05 | GEM-P | N | N | 270017249 | GEMCITABINE + PACLITAXEL |
| 270014261 | 270014637 | null | 56.75 | Adjuvant (A) | 2014-03-19 | 2014-03-21 | Panitumumab | N | Y | 270017249 | NIVOLUMAB |
| 270014262 | 270009915 | 1.49 | 55.7 | null | 2013-06-21 | 2013-07-16 | Cyclophosphamide High Dose | 02 | N | 270017254 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014263 | 270009916 | 1.8 | 90.6 | Not known (9) | 2013-06-26 | 2013-06-27 | Carboplatin AUC 2 - 5 | 02 | N | 270017255 | ABVD R |
| 270014264 | 270009917 | null | 93.6 | Curative (C) | 2013-07-22 | 2013-07-24 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 270017255 | IGEV |
| 270014265 | 270009923 | 1.69 | 98 | Adjuvant (A) | null | 2015-11-13 | Irinotecan 14day | null | N | 270017261 | IRINOTECAN |
| 270014266 | 270009927 | 1.72 | null | Adjuvant (A) | 2015-07-27 | 2015-07-27 | GEM-P | N | N | 270017263 | GEMCITABINE + PACLITAXEL |
| 270014267 | 270009927 | 1.5 | 62.5 | Adjuvant (A) | 2014-05-05 | 2014-05-06 | Cisplatin | N | null | 270017263 | NIVOLUMAB |
| 270014268 | 270014642 | 0 | 70 | Not known (9) | 2017-12-23 | 2017-12-24 | Cetuximab + Oxaliplatin + MdG Maint | 2 | N | 270017269 | VEPEMB |
| 270014269 | 270014642 | null | 87 | Adjuvant (A) | 2017-05-01 | 2017-05-07 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270017269 | CETUXIMAB + OXALIPLATIN + MDG |
| 270014270 | 270009930 | 1.84 | 88.8 | Adjuvant (A) | 2017-05-31 | 2017-06-15 | Carboplatin AUC 6 - 10 | 02 | N | 270017274 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014271 | 270009931 | 1.52 | 54.2 | Adjuvant (A) | 2014-09-20 | 2014-10-04 | GEM-P | N | N | 270017276 | GEMCITABINE + PACLITAXEL |
| 270014272 | 270009934 | 1.66 | 80 | null | 2017-10-30 | 2017-11-03 | GEM-P | 02 | null | 270017276 | GEMCITABINE + PACLITAXEL |
| 270014273 | 270009934 | 1.7 | 93.7 | Palliative (P) | 2014-12-03 | 2014-12-03 | Vinblastine weekly | N | N | 270017276 | BEAM + ALEMTUZUMAB |
| 270014274 | 270009935 | null | 97.5 | Adjuvant (A) | null | 2013-03-11 | IVE | null | Y | 270017287 | IVE |
| 270014275 | 270009942 | 0 | 37 | Disease modification (D) | 2015-02-15 | 2015-03-07 | Carboplatin AUC 6 - 10 | N | N | 270017290 | CARBOPLATIN |
| 270014276 | 270009945 | 1.57 | 62 | Not known (9) | 2014-12-27 | 2015-02-06 | Cyclophosphamide High Dose | Y | N | 270017293 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014277 | 270009948 | 1.86 | 58.2 | Palliative (P) | 2014-04-20 | 2014-04-23 | IVE | 2 | N | 270017301 | IVE |
| 270014278 | 270009950 | 1.64 | 62 | Neo-adjuvant (N) | 2016-08-31 | 2016-10-26 | Panitumumab | N | N | 270017306 | NIVOLUMAB |
| 270014279 | 270009956 | null | 71.7 | Adjuvant (A) | 2017-07-16 | 2017-09-25 | Vinblastine | 02 | N | 270017311 | PANITUMUMAB |
| 270014280 | 270009957 | null | 74 | Palliative (P) | 2014-06-05 | 2014-06-06 | GDP | N | N | 270017315 | GDP |
| 270014281 | 270014654 | 1.75 | null | Adjuvant (A) | 2017-04-11 | 2017-05-08 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270017316 | BEVACIZUMAB |
| 270014282 | 270014654 | 1.78 | 99.7 | Adjuvant (A) | 2015-02-07 | 2015-02-14 | GEM-P | N | N | 270017316 | GEMCITABINE + PACLITAXEL |
| 270014283 | 270009960 | 1.81 | 120.8 | null | 2017-01-18 | 2018-01-20 | NIVOLUMAB | N | N | 270017324 | CISPLATIN |
| 270014284 | 270009961 | 1.67 | 62 | Adjuvant (A) | 2015-03-10 | 2015-04-14 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | null | 2 | 270017328 | OXALIPLATIN + RALTITREXED |
| 270014285 | 270009967 | 0 | 57.5 | Curative (C) | 2017-02-22 | 2017-02-23 | Irinotecan 14day | N | N | 270017330 | IRINOTECAN |
| 270014286 | 270009972 | 1.87 | null | Palliative (P) | 2014-11-21 | 2014-11-30 | NIVOLUMAB | 02 | N | 270017331 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014287 | 270009973 | 0 | 59 | Adjuvant (A) | 2016-05-01 | 2016-05-01 | Bevacizumab 5mg/kg | 02 | N | 270017331 | VEPEMB |
| 270014288 | 270009973 | 1.68 | 63 | null | 2014-01-01 | 2014-01-01 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270017331 | VINBLASTINE |
| 270014289 | 270009974 | 1.73 | null | Not known (9) | null | 2013-06-17 | Carboplatin AUC 6 - 10 | null | null | 270017342 | VEPEMB |
| 270014290 | 270009975 | 1.83 | 79.8 | Adjuvant (A) | null | 2016-12-03 | NIVOLUMAB | N | N | 270017346 | NIVOLUMAB |
| 270014291 | 270009978 | 1.7 | 93.4 | Not known (9) | 2016-04-26 | 2016-04-26 | IVE | 2 | N | 270017347 | IVE |
| 270014292 | 270009978 | 1.69 | 79.6 | Curative (C) | 2016-10-19 | 2016-10-19 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | 270017347 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014293 | 270009980 | 1.64 | null | Adjuvant (A) | 2018-09-06 | 2018-09-06 | GDP | N | N | 270017351 | GDP |